These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17690114)

  • 1. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
    Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB
    Carcinogenesis; 2007 Dec; 28(12):2589-96. PubMed ID: 17690114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y; Zhang Z; Lubet RA; You M
    Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.
    McKenna IM; Ramakrishna G; Diwan BA; Kang Y; Shiao YH; Wakefield LM; Powell DA; Anderson LM; Jakowlew SB
    Toxicol Lett; 2001 Sep; 123(2-3):151-8. PubMed ID: 11641043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.
    Kang Y; Ozbun LL; Angdisen J; Moody TW; Prentice M; Diwan BA; Jakowlew SB
    Carcinogenesis; 2002 Jul; 23(7):1217-27. PubMed ID: 12117781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
    Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma.
    Okudela K; Hayashi H; Ito T; Yazawa T; Suzuki T; Nakane Y; Sato H; Ishi H; KeQin X; Masuda A; Takahashi T; Kitamura H
    Am J Pathol; 2004 Jan; 164(1):91-100. PubMed ID: 14695323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
    Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
    Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.
    Hasegawa Y; Takanashi S; Kanehira Y; Tsushima T; Imai T; Okumura K
    Cancer; 2001 Mar; 91(5):964-71. PubMed ID: 11251948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of lung cancer progression by bexarotene in mouse models.
    Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
    Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-rasG12V mediated lung tumor models identified three new quantitative trait loci modifying events post-K-ras mutation.
    Saito H; Suzuki N
    Biochem Biophys Res Commun; 2014 Oct; 452(4):1067-70. PubMed ID: 25245290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis.
    Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB
    Mol Carcinog; 2004 Aug; 40(4):212-31. PubMed ID: 15264213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
    Tang YJ; Xiao J; Huang XR; Zhang Y; Yang C; Meng XM; Feng YL; Wang XJ; Hui DS; Yu CM; Lan HY
    Am J Respir Cell Mol Biol; 2014 Dec; 51(6):761-71. PubMed ID: 24885478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis.
    Martínez-Salgado C; Fuentes-Calvo I; García-Cenador B; Santos E; López-Novoa JM
    Exp Cell Res; 2006 Jul; 312(11):2093-106. PubMed ID: 16624289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations.
    Hervé V; Rabbe N; Guilleminault L; Paul F; Schlick L; Azzopardi N; Duruisseaux M; Fouquenet D; Montharu J; Redini F; Paintaud G; Lemarié E; Cadranel J; Wislez M; Heuzé-Vourc'h N
    MAbs; 2014; 6(6):1638-48. PubMed ID: 25484066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.